Cancer Stem Cells Market Overview:
Cancer Stem Cells are a tiny subpopulation of cancerous and oncogenic cells that self-renew and are responsible for tumor initiation and development. CSCs are important in tumor start, progression, cell death resistance, therapeutic resistance, and recurrence after treatment and remission.
Market Size Growth Rate:
According to the research report published by the DataM Intelligence, the global cancer stem cells market size was valued at USD billion in 2021, it is projected to reach USD billion by 2029, with growth at a CAGR of 6.7% over the forecast period 2022-2029.
Oncology treatments are entering a new phase, with traditional medicines such as radiotherapy, chemotherapy, and operations on one hand and stem cell therapies on the other. Stem cells have been successfully used in immuno-reconstitution and blood replenishment following tumor formation or treatment for the past few years. Furthermore, these cells have attracted much interest from healthcare organizations since they can be used to administer anti-cancer drugs and regenerate tissue. Many organizations have reported positive results from employing this tumor treatment method, which is expected to drive market growth in the forecast period.
The cancer stem cell market growth is driven by several factors, such as a rise in the incidence and mortality rate worldwide and increased R&D activities related to the development of these medicines. According to the International Agency for Research on Cancer (IARC), around 19.2 million new cancer cases were identified in 2020, with approximately 10 million people dying from cancer. According to NCI, By 2040, the annual number of new cancer cases is predicted to reach 29.5 million, with 16.4 million cancer-related deaths. Hence, the rising prevalence of cancer is expected to drive the demand for the cancer stem cells market in the forecast period.
Clinical concerns relating to stem cell therapy development and implementation is one major factor expected to hinder the market growth. The type of stem cells, their differentiation status and proliferation capacity, the route of administration, the intended location, in vitro culture and/or other manipulation steps, irreversibility of treatment, need/possibility for concurrent tissue regeneration in case of irreversible tissue loss, and long-term survival of engrafted cells all influence the risk profile of stem cell-based medicinal products. These components work together to determine the risk profile of a stem cell-based medical product. Tumor growth, undesired immunological responses, and the transmission of adventitious agents are among the identified dangers (i.e., risks found in clinical experience) or potential/theoretical risks (i.e., risks observed in animal research). All these risk factors during the development and implementation of cancer stem cells are expected to hamper the market growth.
The rising applications of cancer stem cells and increasing research is expected to create large opportunities in the forecast period. For instance, stem cells modified to persistently express multiple cytotoxic drugs in preclinical animal models reduce tumor sizes and extend longevity. They’ve also been used to carry viruses and nanoparticles to improve primary medicinal efficacies and reduce side effects. Stem cells can also be used in regenerative medicine, immunotherapy, cancer stem cell-targeted therapy, and pharmacological screening for anticancer drugs.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/cancer-stem-cells-market
COVID-19 Impact Analysis
COVID-19 has damaged numerous industries, including the cancer stem cell market, as a result of the ongoing COVID – 19 pandemic, which has resulted in more than four million illnesses and economies. The lack of optimal vector production capacity is a major challenge in the cancer stem cell industry. The ongoing COVID-19 pandemic and the consequences of lockdowns in numerous nations worldwide are anticipated to put pressure on vector manufacturers to fulfill future demand for cancer cell therapies. The stem cell manufacturing sector is still in its early phases of growth, with producers attempting to discover better solutions to the obstacles that remain.
Recent Developments in the Industry:
On October 1st, 2021, The FDA approved the use of brexucabtagene autoleucel (Tecartus), a CAR T-cell therapy, for adults with B-cell precursor ALL who have not responded to treatment (refractory) or who have returned after treatment. Brexucabtagene is the first CAR T-cell treatment approved for people with ALL (acute lymphoblastic leukemia).
As per the research analysis, the cancer stem cells market is segmented by cancer type into blood cancer, breast cancer, colorectal cancer, lung cancer, liver cancer, brain cancer, and others. The market is further segmented by mode of action into stem cell-based cancer therapy and targeted cancerous stem cells (cscs).
On the basis of cancer type, the breast cancer segment is estimated to grow at the highest CAGR of YY during the forecast period (2022-2029). The cancer segment is accounted for the largest market share of YY of the global cancer stem cells market in 2020. According to NCI, Breast cancer is the most common cancer on the list, with 290,560 new cases projected in the United States in 2022.
According to the report the market is divided into North America, South America, Europe, Asia-Pacific and Middle East.
North America Cancer Stem Cells Market:
North America is found to dominate the market as the United States and Canada have well-structured and developed healthcare systems. These countries are found to promote research and development for cancer stem cells and increasing prevalence of cancer is expected to boost the market growth.
Asia Pacific Cancer Stem Cells Market:
The Asia-Pacific cancer stem cells market size was valued at USD YY billion in 2021, it is projected to reach at USD YY billion by 2029, with growth at a CAGR of YY% over the forecast period 2022-2029.
The major players are adopting several growth strategies such as acquisitions, product pipeline and collaborations, which are contributing to the growth of the cancer stem cells market globally.
Some of the key players which are contributing to the growth of the market include Merck KgaA,Thermo Fisher Scientific, Inc., Bionomics., AbbVie, Inc., Stemline Therapeutics, Inc, LONZA, PromoCell GmbH, Miltenyi Biotec, STEMCELL Technologies Inc, BIOTIME, Inc and others.
Make an Inquire before purchasing the full report @ https://www.datamintelligence.com/enquiry/cancer-stem-cells-market
Additional Benefits Post Purchase:
1) Unlimited Analyst support for a period of 1 year.
2) Any query with regards to the scope offered will be addressed within 24- 48 hours.
3) An excel sheet with market numbers will be provided separately.
The Full Report has the below insights
The report offers a comprehensive evaluation of the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
Visualize the composition of the Global Cancer Stem Cells Market segmentation by cancer type, mode of action and region highlighting the key commercial assets and players.
By Cancer Type: Blood cancer, breast cancer, colorectal cancer, lung cancer, liver cancer, brain cancer and others
By Mode of Action:Stem cell-based cancer therapy and targeted cancerous stem cells (cscs).
By Region: North America, South America, Europe, Asia-Pacific and Middle East
Identify commercial opportunities in the Global Cancer Stem Cells Market by analyzing trends and co-development deals.
The report also covers data insights on various industry forces such as, porter’s five forces, regulations in each country, Pipeline analysis and pricing analysis.
Excel data sheet with thousands of data points Global Cancer Stem Cells Market-level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The report will provide access to approximately 50+ market data tables, 40+ figures, and close to 180 pages.
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States